189
+3.85%
Close of 9 Nov 2026, in JPY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Precision System Science Co
Its shares trade on Tokyo Stock Exchange under the ticker 7707.T. It has been listed since 1 February 2001. In the fiscal year to 30 June 2026, it reported revenue of ¥5.22bn and net income of ¥394.9m. At that date it held total assets of ¥5.85bn and shareholders' equity of ¥4.09bn.
Precision System Science Co., Ltd. engages in the development, manufacture and sale of automated systems, physicochemical instruments, and reagents. The company is headquartered in Matsudo-Shi, Chiba-Ken. The company went IPO on 2001-02-01. The equipment business provides various automated equipment for lab such as deoxyribonucleic acid (DNA) automatic extractors and others, immunochemical luminescence measuring devices, specimen pretreatment devices for clinical diagnosis, and fully automated gene diagnostic equipment, among others. The reagents and consumables business provide various reagents used for DNA extraction and protein purification, as well as dedicated plastic consumables such as reaction vessel and others. The maintenance-related segment is engaged in equipment maintenance business, and the sales of spare parts (replacement parts). The contract manufacturing business is engaged in the contract manufacturing business.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Life Sciences Tools & Services
- Listed since
- 1 Feb 2001
- Employees
- 166
- Website
- pss.co.jp ↗
Leadership
Pay as last reported
- Mr. Hideji TajimaPresident, Chief Executive Officer, President of Subsidiaries, Representative Director, since 1989
- Ms. Yu SugiyamaPresident, Representative Director, since 2023
- Mr. Hideo IkedaSenior Managing Director, President of Subsidiary, since 2011
- Mr. Akihiro FurukawaManaging Director, Chief Executive Officer of Subsidiary, since 2015
- Mr. Hideki TanakaDirector of General Affairs, Director, since 2018
- Ms. Kazumi SawakamiDirector, since 2020
- Mr. Daisuke OgiwaraIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Precision System Science Co Ltd (PSS) boasts a strong foundation built upon advanced technology and continuous innovations. The company has consistently strived to stay ahead of the curve in the scientific and diagnostic industry, constantly developing cutting-edge products and solutions.
- PSS has successfully established a robust market presence, gaining recognition as a reliable and reputable provider of laboratory equipment and systems. Partnering with numerous renowned organizations and having a global customer base, the company enjoys a strong market share and brand reputation.
Weaknesses
- A potential weakness for PSS lies in its limited product range. While the company excels in its core areas, it may not offer a comprehensive selection of products in comparison to some competitors. This limitation could restrict opportunities for market expansion or lead to potential revenue loss.
- PSS relies on external suppliers for certain key components utilized in its products. This dependence exposes the company to potential disruptions in the supply chain, such as shortages, quality control issues, or sudden price fluctuations. Mitigating this risk successfully requires effective supplier management strategies.
Opportunities
- The scientific and diagnostic industry is experiencing significant growth, driven by factors such as increased medical research, precision medicine advancements, and the rising need for diagnostic tools. PSS can capitalize on this favorable market trend by expanding its product portfolio and catering to evolving customer demands.
- PSS has the opportunity to tap into emerging markets with untapped potential. By strategically entering and establishing a presence in new geographical regions, the company can unlock new revenue streams and broaden its customer base, further strengthening its market position and profitability.
Threats
- The scientific and diagnostic industry is fiercely competitive, with numerous players vying for market share. PSS faces the threat of intense competition from both established companies and emerging startups. The company needs to continuously differentiate itself through product innovation, pricing strategies, and exceptional customer service to mitigate this threat.
- Operating in the scientific and diagnostic industry entails navigating complex regulatory requirements and compliance standards. Failure to comply with applicable regulations can lead to significant penalties and damage the company's reputation. PSS must prioritize compliance efforts and stay abreast of evolving regulations to manage this threat effectively.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.